Abstract:Potentilla nepalensis belongs to the Rosaceae family and has numerous therapeutic applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and stem through n-hexane (NR and NS) and methanolic (MR and MS) extracts were identified in earlier studies. However, the PCs affecting human genes and their roles in the body have not previously been disclosed. In this study, we employed network pharmacology, molecular docking, molecular dynamics simulations (MDSs), and MMGBSA methodologies. The SMILES format of PCs from the PubChem was used as input to DIGEP-Pred, with 764 identified as the inducing genes. Their enrichment studies have shown inducing genes' gene ontology descriptions, involved pathways, associated diseases, and drugs. PPI networks constructed in String DB and network topological analyzing parameters performed in Cytoscape v3.10 revealed three therapeutic targets: TP53 from MS-, NR-, and NS-induced genes; HSPCB and Nf-kB1 from MR-induced genes. From 40 PCs, two PCs, 1b (MR) and 2a (MS), showed better binding scores (kcal/mol) with p53 protein of −8.6 and −8.0, and three PCs, 3a, (NR) 4a, and 4c (NS), with HSP protein of −9.6, −8.7, and −8.2. MDS and MMGBSA revealed these complexes are stable without higher deviations with better free energy values. Therapeutic targets identified in this study have a prominent role in numerous cancers. Thus, further investigations such as in vivo and in vitro studies should be carried out to find the molecular functions and interlaying mechanism of the identified therapeutic targets on numerous cancer cell lines in considering the PCs of P. nepalensis.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of phytoconstituents (PCs) in *Potentilla nepalensis*, a plant unique to the Himalayan region, on human genes and their potential roles in the discovery of cancer treatment targets. Specifically, through comprehensive strategies such as network pharmacology, molecular docking, molecular dynamics simulation, and MMGBSA analysis, the study aims to identify the human genes affected by these phytoconstituents and evaluate their potential as cancer treatment targets. ### Research Background and Objectives - **Research Background**: *Potentilla nepalensis* belongs to the Rosaceae family and is widely used in traditional medicine, especially for the active constituents in the extracts of its roots and stems, with multiple therapeutic applications. However, how these active constituents affect human genes and their in - vivo mechanisms of action have not been fully revealed. - **Research Objectives**: Through network pharmacology, molecular docking, molecular dynamics simulation, and MMGBSA analysis, systematically study the effects of 40 active constituents in *Potentilla nepalensis* on human genes, especially whether these constituents can be potential targets for cancer treatment. ### Main Research Methods 1. **Compound Retrieval**: - 40 active constituents were extracted from the roots and stems of *Potentilla nepalensis* using n - hexane and methanolic extraction methods respectively. - The SMILES format, PubChem ID, and 2D structure of these active constituents were obtained from the PubChem database. 2. **Gene Induction Analysis**: - The DIGEP - Pred tool was used to predict the genes induced by these active constituents, and a total of 764 induced genes were identified. - Enrichment analysis was performed on these induced genes, including Gene Ontology (GO) descriptions, involved pathways, related diseases, and drugs. 3. **Protein - Protein Interaction Network Construction**: - The String DB was used to construct a protein - protein interaction network (PPI), and network topological parameter analysis was carried out through Cytoscape v3.10. - Three main treatment targets were identified: TP53 (from MS, NR, and NS - induced genes), HSPCB, and Nf - kB1 (from MR - induced genes). 4. **Molecular Docking**: - The Autodock Vina software was used for molecular docking to evaluate the binding affinities between the active constituents and key proteins such as p53, HSP proteins, and Nf - kB1. - The results showed that the binding energies of 1b (MR) and 2a (MS) to the p53 protein were - 8.6 and - 8.0 kcal/mol respectively; the binding energies of 3a (NR), 4a, and 4c (NS) to the HSP protein were - 9.6, - 8.7, and - 8.2 kcal/mol respectively. 5. **Molecular Dynamics Simulation and MMGBSA Analysis**: - Molecular dynamics simulation (MDS) and MMGBSA free - energy calculations were carried out to evaluate the stabilities and free - energy values of the above - mentioned binding modes. - The results indicated that these complexes showed good stabilities during the simulation process and had low free - energy values. ### Main Conclusions - **Treatment Target Identification**: The study successfully identified TP53, HSPCB, and Nf - kB1 as potential treatment targets for the active constituents of *Potentilla nepalensis*. - **Binding Mode Analysis**: Through molecular docking and molecular dynamics simulation, the binding modes between the active constituents and these target proteins were analyzed in detail, providing a theoretical basis for further in - vivo and in - vitro experiments. - **Future Research Directions**: It is recommended to further carry out in - vivo and in - vitro experiments to verify the molecular functions and mechanisms of action of these active constituents in multiple cancer cell lines. In conclusion, this study provides an important scientific basis for the potential application of *Potentilla nepalensis* in cancer treatment and lays the foundation for further drug development.

Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery

A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: an updated prototype in drug discovery

Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma

An in-silico investigation and network pharmacology based approach to explore the anti-breast-cancer potential of Tecteria coadunata (Wall.) C. Chr

IN SILICO PHARMACOKINETICS AND MOLECULAR DOCKING OF THREE LEADS ISOLATED FROM TARCONANTHUS CAMPHORATUS L

Network pharmacology and bioinformatics based investigation of Phyllanthus fraternus: herb-drug interaction study

Deciphering the multi-scale mechanism of herbal phytoconstituents in targeting breast cancer: a computational pharmacological perspective

In silico evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in Pleurotus ostreatus extracts

In Silico Pharmacokinetic and Molecular Docking Studies of Natural Plants against Essential Protein KRAS for Treatment of Pancreatic Cancer

Network pharmacology and molecular docking to elucidate the mechanism of pulsatilla decoction in the treatment of colon cancer

Network pharmacology-integrated molecular docking analysis of phytocompounds of Caesalpinia pulcherrima (peacock flower) as potential anti-metastatic agents

Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment

Network pharmacology-based anti-colorectal cancer activity of piperlonguminine in the ethanolic root extract of Piper longum L

Network Pharmacology Approach for Medicinal Plants: Review and Assessment

Identification of novel AKT1 inhibitors from Sapria himalayana bioactive compounds using structure-based virtual screening and molecular dynamics simulations

Fritillaria steroidal alkaloids and their multi-target therapeutic mechanisms: insights from network pharmacology

Metabolomics and network pharmacology-based identification of phenolic acids in Polygonatum kingianum var. grandifolium rhizomes as anti-cancer/Tumor active ingredients

A Systems-Level Analysis of Mechanisms of Platycodon grandiflorum Based on A Network Pharmacological Approach

Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer

UPLC-Q-Exactive-MS Combined with Network Pharmacology to Explore the Antitumor Effect of Polygonatum sibiricum Leaf Tea

Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies